Naglazyme®
2014LS014
Unknown small_molecule terminated
Quick answer
Naglazyme® for Maroteaux-Lamy Syndrome is a Unknown program (small_molecule) at BIOMARIN PHARMACEUTICAL INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOMARIN PHARMACEUTICAL INC
- Indication
- Maroteaux-Lamy Syndrome
- Phase
- Unknown
- Modality
- small_molecule
- Status
- terminated